Cargando…
Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis
An automated risk prediction assay has previously been shown to objectively identify patients with nondysplastic Barrett's esophagus (NDBE) who are at increased risk of malignant progression. To evaluate the predictive performance of the assay in 76 patients with NDBE of which 38 progressed to...
Autores principales: | Frei, Nicola F., Konte, Kadère, Bossart, Emily A., Stebbins, Katelyn, Zhang, Yi, Pouw, Roos E., Critchley-Thorne, Rebecca J., Bergman, Jacques J.G.H.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544172/ https://www.ncbi.nlm.nih.gov/pubmed/33108124 http://dx.doi.org/10.14309/ctg.0000000000000244 |
Ejemplares similares
-
An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus
por: Duits, Lucas C., et al.
Publicado: (2023) -
Management of nondysplastic Barrett’s esophagus: When to survey? When
to ablate?
por: Puthenpura, Max M., et al.
Publicado: (2022) -
The SpaTemp cohort: 168 nondysplastic Barrett’s esophagus surveillance patients with and without progression to early neoplasia to evaluate the distribution of biomarkers over space and time
por: Frei, N F, et al.
Publicado: (2020) -
Incidence of Dysplasia in Obese vs Nonobese Patients With Nondysplastic Barrett Esophagus
por: Monardo, Ann, et al.
Publicado: (2019) -
The incidence of esophageal cancer and dysplasia in a Chinese population with nondysplastic Barrett's esophagus
por: Lee, Shou‐Wu, et al.
Publicado: (2018)